BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Cipla
AstraZeneca
Covington
Federal Trade Commission
McKesson
Citi
Teva
Colorcon

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,866,581

« Back to Dashboard

Summary for Patent: 5,866,581
Title: Penciclovir for the treatment of post therapeutic neuralgia
Abstract:A method for the treatment of PHN in mammals, including humans, which method comprises administering an effective amount of a compound of formula (A), or a pharmaceutically acceptable salt thereof. ##STR1##
Inventor(s): Boon; Ronald James (Dorking, GB2), Griffin; David Ronald John (Bishop's Stortford, GB2)
Assignee: SmithKline Beecham p.l.c. (Brentford, GB2)
Application Number:08/624,466
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,866,581

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,866,581

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9320485Oct 05, 1993
United Kingdom9321255Oct 14, 1993
PCT Information
PCT FiledOctober 04, 1994PCT Application Number:PCT/GB94/02156
PCT Publication Date:April 13, 1995PCT Publication Number: WO95/09632

International Patents Family Members for US Patent 5,866,581

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 616 ➤ Subscribe
African Regional IP Organization (ARIPO) 9400684 ➤ Subscribe
Austria 216885 ➤ Subscribe
Australia 1383495 ➤ Subscribe
Australia 697290 ➤ Subscribe
Australia 7788494 ➤ Subscribe
Canada 2173505 ➤ Subscribe
Canada 2179282 ➤ Subscribe
China 1082816 ➤ Subscribe
China 1084622 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Novartis
Mallinckrodt
Fish and Richardson
Dow
Cerilliant
QuintilesIMS
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot